Vitiligo in a patient with metastatic melanoma receiving human immunoglobulin G4 monoclonal antibody-nivolumab treatment.

MLA

Gökşin, Şule, and Serkan Değirmencioğlu. “Vitiligo in a Patient with Metastatic Melanoma Receiving Human Immunoglobulin G4 Monoclonal Antibody-Nivolumab Treatment.” Turkderm - Turkish Archives of Dermatology & Venereology, vol. 56, no. 3, July 2022, pp. 135–37. EBSCOhost, https://doi.org/10.4274/turkderm.galenos.2022.47527.

APA

Gökşin, Ş., & Değirmencioğlu, S. (2022). Vitiligo in a patient with metastatic melanoma receiving human immunoglobulin G4 monoclonal antibody-nivolumab treatment. Turkderm - Turkish Archives of Dermatology & Venereology, 56(3), 135–137. https://doi.org/10.4274/turkderm.galenos.2022.47527

Chicago

Gökşin, Şule, and Serkan Değirmencioğlu. 2022. “Vitiligo in a Patient with Metastatic Melanoma Receiving Human Immunoglobulin G4 Monoclonal Antibody-Nivolumab Treatment.” Turkderm - Turkish Archives of Dermatology & Venereology 56 (3): 135–37. doi:10.4274/turkderm.galenos.2022.47527.